Mount Sinai Health System celebrated its 34th annual Crystal Ball party by honoring Peter W. May, Chairman of Mount Sinai’s Boards of Trustees since 2002.
In honor of National Women’s Health Week, the REACH Program (Respectful and Equitable Access to Comprehensive Healthcare) at Mount Sinai is hosting a Women’s Health Fair for the Harlem and surrounding communities.
Mount Sinai researchers have broken new ground in the understanding of the MDM2 gene—which is often overexpressed in cancer—finding that when it acts with a specific protein, it can lead to cancer cell death. The study appears in the May 2, 2019, print edition of Molecular Cell.
In the largest study of its kind, researchers have identified 20 new genetic associations with one of the most prevalent and elusive mental illnesses of our time—bipolar disorder.
Mount Sinai researchers found significant delays in reporting human cases of West Nile virus, hampering real-time forecasting of the potentially deadly mosquito-borne disease, according to a study in the JAMA Network Open in April.
In recognition of May’s Melanoma Monday and Skin Cancer Awareness Month, Mount Sinai Health System experts are using state of the art devices to detect early skin cancers, arming the public with vital tips on prevention and offering free skin cancer screenings.
Mount Sinai has received a $6 million donation from the Derfner Foundation to name the new Plastic and Reconstructive Surgery suite within the Department of Surgery
Researchers at Mount Sinai have developed a novel approach to cancer immunotherapy, injecting immune stimulants directly into a tumor to teach the immune system to destroy it and other tumor cells throughout the body.
The Nash family, whose philanthropic generosity has supported many important initiatives within the Mount Sinai Health System over nearly three decades, has made a new contribution to establish the Nash Family Center for Advanced Circuit Therapeutics at Mount Sinai.
In the largest study of its kind, involving more than 100,000 people, researchers at the Icahn School of Medicine at Mount Sinai have applied a novel machine learning method to identify 413 genetic associations with schizophrenia across 13 brain regions.
Researchers have developed an artificial intelligence platform to detect a range of neurodegenerative disease in human brain tissue samples, including Alzheimer’s disease and chronic traumatic encephalopathy.
Robert H. Pass, MD, a nationally and internationally renowned pediatric cardiologist, has been appointed Division Chief of Pediatric Cardiology and Director of Pediatric Electrophysiology at the Mount Sinai Health System. He will also be Co- Director of the Children’s Heart Center.an alliance between the Mount Sinai Health System and Children's Hospital of Philadelphia, two world-leading institutions that provide an unprecedented scope of services for pediatric heart patients.
Diagnostic device company OOVA, Inc., a Mount Sinai Health System spinout, is piloting a fertility monitoring tool through a partnership with Thorne Research
As part of nationwide efforts to improve emergency medical care, researchers at the Mount Sinai Health System, in collaboration with UC San Diego Health, have released a national framework report titled “Promoting Innovations in Emergency Medical Services” that identifies regulatory, financial, and technological obstacles to improving local and state EMS systems.
The Department of Rehabilitation and Human Performance at the Mount Sinai Health System has become the official medical services provider on the East Coast for U.S. Red Bull athletes and Red Bull’s athlete performance programs.
In honor of American Heart Month in February, the Mount Sinai Health System will host several “Go Red" Community Heart Health Fairs throughout its system.
The Icahn School of Medicine at Mount Sinai has entered into two exclusive licenses to develop the drug pentosan polysulfate sodium for the treatment of mucopolysaccharidosis (MPS).
Herpes viral infections use the ancient genetic material found in the human genome to proliferate, mimicking the same process tumors have been found to manipulate, Mount Sinai researchers have shown for the first time. These observations provide further insight about how herpes viruses can manipulate the immune system in ways that may drive neurodegenerative diseases like Alzheimer’s, according to the study, published in Nature Communications in January.
The Department of Urology at the Mount Sinai Health System has partnered with the nonprofit organization Man Cave Health to launch a first-of-its-kind sports-themed resource center for men that will provide educational resources on prostate health.